A comprehensive view of Regeneron Pharmaceuticals Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Bioeconomy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Australia: Regeneron Pharmaceuticals, Sanofi Biotechnology Receive Patent for 'Compositions for the treatment of rheumatoid arthritis and methods of using same'
Published: April 19, 2024 by Australian Government
Australia: Regeneron Pharmaceuticals Receives Patent for 'Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist'
Published: April 19, 2024 by Australian Government
Australia: Regeneron Pharmaceuticals Receives Patent for 'Devices and methods for precision dose delivery'
Published: April 19, 2024 by Australian Government
Regeneron Pharma Granted United States Patent for High Confidence Compound Identification by Liquid Chromatography-Mass Spectrometry
Published: April 18, 2024 by Pharmaceutical Patent News
INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER WITH BISPECIFIC EGFR X CD28 ANTIBODIES ALONE OR IN COMBINATION WITH ANTI-PD-1 ANTIBODIES"
Published: April 17, 2024 by U.S. Fed News

Ask us about our Bioeconomy market view

Trending Chart

Interactive chart with headline count